2022
DOI: 10.1016/s1470-2045(21)00639-2
|View full text |Cite
|
Sign up to set email alerts
|

Toxicity and efficacy of chronomodulated chemotherapy: a systematic review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
39
0
1

Year Published

2022
2022
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 46 publications
(40 citation statements)
references
References 50 publications
0
39
0
1
Order By: Relevance
“…For example, pharmacological activation of REV-ERBs and RORs were reported to induce lethality in CRC [ 52 , 53 ] and a chrono-modulated FOLFOX treatment in metastatic CRC patients resulted in survival advantage over conventional treatment, especially in men [ 18 ]. In a recent systematic review of 18 clinical studies with 2547 cancer patients (e.g., colorectal, nasopharyngeal, endometrial and ovarian cancer) the authors concluded that chronomodulated chemotherapy resulted in reduced treatment toxicity while maintaining treatment efficacy in most cases (61% of the studies), compared with conventional therapy regimens [ 54 ]. Since MACC1 also acts as a therapeutic target restricting CRC progression and metastasis [ 24 ], a circadian MACC1 regulation is likely to affect the efficacy of treatment and would be expected to be circadian time-dependent.…”
Section: Discussionmentioning
confidence: 99%
“…For example, pharmacological activation of REV-ERBs and RORs were reported to induce lethality in CRC [ 52 , 53 ] and a chrono-modulated FOLFOX treatment in metastatic CRC patients resulted in survival advantage over conventional treatment, especially in men [ 18 ]. In a recent systematic review of 18 clinical studies with 2547 cancer patients (e.g., colorectal, nasopharyngeal, endometrial and ovarian cancer) the authors concluded that chronomodulated chemotherapy resulted in reduced treatment toxicity while maintaining treatment efficacy in most cases (61% of the studies), compared with conventional therapy regimens [ 54 ]. Since MACC1 also acts as a therapeutic target restricting CRC progression and metastasis [ 24 ], a circadian MACC1 regulation is likely to affect the efficacy of treatment and would be expected to be circadian time-dependent.…”
Section: Discussionmentioning
confidence: 99%
“…The circadian system is an emerging field in cancer therapy, as it plays an important role in drug metabolism and consequently in treatment toxicity, tolerability and efficacy of treatment [ 7 , 11 , 29 ]. However, the role of natural plant extracts upon circadian clock modulation is far from being understood.…”
Section: Discussionmentioning
confidence: 99%
“…Among these are the cell cycle/cell proliferation and metabolism [ 4 , 5 , 6 ]. Malfunctions of the circadian clock are associated with different pathologies, including cancer and studies have linked the disruption of the clock to an enhanced susceptibility to develop cancer, bad treatment response and poor prognosis [ 7 , 8 , 9 , 10 , 11 ].…”
Section: Introductionmentioning
confidence: 99%
“…L'administration de médicaments à un moment précis de la journée, ou chronothérapie, peut s'avérer bénéfique pour mieux traiter ces maladies, en améliorant l'efficacité des médicaments et en réduisant les effets indésirables [50]. Si la chronothérapie est encore peu considérée dans le traitement des maladies inflammatoires, cette stratégie a pourtant été utilisée avec succès dans des maladies comme les cancers, indiquant la faisabilité et la pertinence d'une telle approche [51][52][53].…”
Section: Liens D'intérêtunclassified